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PROFORMA FOR PREVALENCE OF SEXUALLY TRANSMITTED 
DISEASES IN INFERTILE WOMEN 
 
 
 
Name  
 
Age    O.P. No  
 
 
Occupation   Socioeconomic status 
 
Address 
 
Duration of married life   yrs.   mths 
 
Presenting complaints –     anxious to conceive 
 
Irregular menstrual cycle    yes   no 
 
Vaginal discharge      nil        yes 
 
 Duration   <3 mths   >3 mths 
 
 
 Quality  mucoid  mucopurulent  blood stained 
 
 Quality scanty  profuse 
 
 Foul smeeling         yes    no 
 
 Itching  yes    no 
 
Genital ulcer          yes  no 
 
Burning micturition  yes    no 
 
Lower abdominal pain    yes       no 
 
 
Monogamous for past 3 months   yes      no 
  
  Extramarital contact  
  
 
  Premarital contact 
 
Contraception yes           no 
 
 Barrier  
 
 Non-barrier 
 
Frequency of coitus per week     <3      >3 
 
Past history of STD / PID & treatment received 
 
History of other illnesses T.B,D.M,H.T, Hypothyroidism 
 
Family history of infertility 
 
Previous obstetric history – Spontaneous abortion 
     
    Still birth 
 
    Neonatal death 
 
Clinical examination : 
 
 Breast 
 
 Inguinal lymphadenopathy 
 
 Per abdomen         tenderness    mass 
  
 External genitalia 
 
 Per speculu – Vaginal secretions 
 
   Cervix 
 Per vagina 
Investigations 
 
Hb   TC   ESR 
 
 
PCV   DC  
 
Urine – Albumin  sugar   deposits 
 
Wet film for Trichomonas 
 
KOH mount for candida 
 
Culture for candida 
 
Gram stain for  candida  clue cells    gonococcus 
 
Endocervical culture for gonococcus 
 
Chlamydia antigen detection test 
 
Chlamydia IgM antibody ELISA test 
 
VDRL 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 1.  INTRODUCTION 
 
 
Epidemiology of STI 
In many developing countries through  out the world  Sexually  Transmitted 
Infections rank among the top 5 conditions for which adults seek health care 
(WHO/UNAID). Especially in women of child bearing age. Sexually  Transmitted 
Infections are second only to maternal factors as a cause of disease death & 
healthy life lost. 
Sexually Transmitted diseases (STD’s) are an important cause of morbidity 
and  mortality worldwide especially in women and children and more particularly 
in the poor resource setting of the developing world. 
These diseases are important for two reasons 
1. Their magnitude 
2. Their potential for causing serious complications. 
STIs Global Face 
WHO estimated that 340 million new cases of syphilis, chlamydia and 
trichomoniasis have occurred throughout the world in 1999 in men & women aged 
15-49 years of age. 
 
 
STI in India 
An overview  
¾ It is estimated that STI prevalence in Urban areas will be  
10% -  High Prevalent states 
7% - Medium Prevalent states 
5% - Low Prevalent states 
Same for Male & Female 
Rural – 5% 
Source – NACO – Publication – combating HIV / AIDS in India – 2000 – 01) 
¾ Prevalence of  classical STIs in Tamilnadu as per the study conducted 
by APAC in 2004 – 10.6% in the age group of 15 – 45 yrs. 
Sexually transmitted infections have implications which are rather serious in 
women than in men. 
The symptoms and sequale of STI vary from men & women and the latter 
experience a greater psychological stress. 
Asymptomatic STI are more frequent in women. Very often, the disease 
presents in a concealed site, not visible outside. Moreover the most common 
symptom of STI in the women namely the discharge is exhibited by many non STI 
and masks – early recognition of STI in such women and so there is delay in 
seeking treatment or is not treated at all. 
 
The long term complications of STI are far more serious in women than in 
men. The important complications are risk of cancer, infertility, miscarriage, still 
birth and risk of ectopic pregnancy and inadvertent transmission of perinatal 
infection. 
Infertility is defined as one year of unprotected intercourse without 
pregnancy. This condition may be further classified as primary infertility in which 
no previous pregnancy has occurred, and secondary infertility in which previous 
pregnancy has occurred. 
Infertility affects about 10-15% of the couple in reproductive age group. 
Tubal factors causing infertility is 30-40%. 
The risk for infertility after a single bout of PID is surprisingly high and 
increased rapidly with subsequent episodes. In fact the incidence of tubal 
infertility has been reported to be 12% ; 23% & 54% after one two (or) three 
episodes of PID respectively. 
Most of these women are presumed to have had subclincial chlamydial 
infections. 
 
 
Lower genital tract infections that ascend into the upper genital tract (IUD’s 
cause four fold increase in PID) can produce inflammation and scarring that 
decreases the chance of intratubal fertilization. 
Hence screening of STDs and partner notification should be done in all 
infertile women. 
 
 
 
 
 
 
 
 
 
 
 
 
  
2.  AIM OF THE STUDY 
 
 
 
To determine the prevalence of sexually transmitted diseases among 
infertile women attending the infertility clinic in Raja Sir Ramasamy Mudaliar 
Lying-in Hospital, Govt. Stanley Medical College – Chennai and therefore 
determine which infections had higher prevalence so that cost effective screening 
and strategies for primary prevention could be incorporated to prevent PID and 
therefore PID associated infertility.  
 
 
 
 
 
 
 
 
 
 3.  REVIEW OF LITERATURE 
SEXUALLY TRANSMITTED INFECTIONS 
 
CHLAMYDIA TRACHOMATIS 
Most common sexually transmitted disease in women of reproductive age. 
Chlamydia trachomatis was first visualized by Halberstaedter and Prowazek in 
1907 in stained conjuctival scraping taken from Orangutans that have been 
inoculated with human trachoma materials. They quickly identified the typical 
intra cytoplasmic inclusions, but initially assumed that the organisms belonged to 
protozoa. The first isolates of Chlamydia from the genital tract was made in 1959 
by Collier and Smith from the cervix of the mother of an infant with “Ophthalmia 
neonatorum”. 
It is a slow growing intracellular organism. Its lack of mitochondria results in 
the obligatory intracellular existence and also causes its growth cycles extremely 
slow compared to C N.gonorrhea and non intracellular microorganism. 
The growth cycle of chlamydia is 48-72hrs therefore, several weeks to 
months required for growth to reach numbers sufficient to cause acute symptoms. 
Its slow growth does not induce violent inflammatory response. This explains low 
and insidious nature of symptoms of acute C.trachomatis infection. However intra 
cellular growth and release of elementary bodies occur by rupture of the cell it has 
 
invaded. The repeated occurrence of elementary body infection of susceptable 
cells and their subsequant destruction by rupture is the major mechanism by which 
c.trachomatis causes disease in acute pelvic infection. Also because of its slow 
growth and lack of acute inflammatory response and clinical symptoms treatment 
is often delayed or not started at all. 
The lack of acute symptoms doesnot lessen the importance of chlamydia, as a 
PID pathogen. Tissue destruction results in ectopic pregnancy & infertility. 
The cervix and urethra are commonly involved. Infection is asymptomatic in 
about 80% of the patients. In other it is associated with vaginal discharge / dysuria. 
Postcoital, or intermenstuat bleeding may suggest PID. Examinations may reveal 
mucopurulent cervicitis, contact bleeding form cervix. Evidence of PID may not 
be present. Without treatment complications develop with the risk of tubal damage 
resulting in subsequent infertility or ectopic pregnancy. 
Among women in the reproductive age group, risk factors for Chlamydia 
infection include : 
1. Age below 25 yrs 
2. Use of intrauterine devices and non use of barrier contraception 
3. Coital frequency 
 
4. Sex with multiple partners 
5. Vaginal douching 
6. Surgical procedures like dilatation and curettage, hystero salpingography 
and IUD insertion. 
7. Presence of mucopurulent endocervicitis, cervical erythema and friability. 
8. Partner with non gonococcal urethritis 
9. Presence of other STDs 
10. Alcohol, cigarette smoking and illicit drug use 
11. Resident of socially disadvantaged community 
DIAGNOSIS OF CHLAMYDIA INFECTION 
1. Cell Culture System 
2. Smear examination 
a. Conventional gram stain 
b. Micro immunofluorescence 
3. Serology 
4. DNA hybridization 
5. Nucleic acid amplification 
CULTURE 
 
Being an obligate intracellular pathogen, Chlamydia trachomatis requires a 
cell culture system for propagation in the laboratory, therefore culture in 
cycloheximide – treated McCoy cells has been the gold standard test for detection 
of Chlamydia for many years. 
DIRECT IMMUNO FLUORESCENCE TEST 
This test is used to detect the chlamydial antigen by adding fluorescent 
labeled monoclonal antibody. When done by an experienced technician it has a 
sensitivity of 80-85% but overall sensitivity depends on both the experience of the 
person performing the test and collection of adequate specimens. 
NUCLEIC ACID HYBRIDIZATION  (Geneprobe Test) 
This test detects but does not amplify chlamydial nucleic acid. Performance 
characteristics on specimens are comparable to that of direct fluorescent antibody 
assay and enzyme immunosorbent assays. Sensitivity. Ranges between 72.9% and 
95.8%, specificity between 97.6% to 99.9%. 
SEROLOGICAL METHODS 
These have not been widely used for the diagnosis of Chlamydia 
trachomatis. First the baseline prevalence of antibody in populations of sexually 
active persons who are at risk for Chlamydia trachomatis infection is high, often 
 
ranging form 45-65% of person tested. The high prevalence of sero-positivity in 
culture negative, asymptomatic patients presumably reflects either previous 
infection or persistence of chronic asymptomatic infection not easily detected with 
current culture technique. 
Second, the lack of an abrupt onset of symptoms in many Chlamydia 
infected patients means that patients are seen often during periods when IgM 
antibody is rising and falling titres of IgM antibody cannot be demonstrated and 
hence these serologic parameters of recently acquired infection often are absent. 
This particularly applies to women as compared to men. 
Third, the superficial genital tract infection (urethritis, cervicitis) generally 
produce micro IF antibody titres in the range of 1:8 to 1:256, but rarely higher. 
Higher antibody titres are more often seen in women with salpingitis and still 
higher titres in women with perihepatitis. 
Finally, cross reacting antibodies arising due to Chlamydia pneumonia may 
confuse the diagnosis serologically. 
GONORRHOEA 
Gonorrhoea is caused by infection with Neisseria Gonorrhoea which may 
involve, columar epithelium in the lower genital tract and rectum. In addition, 
urethra, para urethral gland, duct and endocervical canal may be involved.  
 
50% of the cases – asymptomatic 50% - Vaginal discharge /  dysuria may 
be associated with other symptoms. Clinical examination may show no 
abnormality or pus may be expressed from the urethra, para urethral duct or 
Bartholin duct. 
The cervix may be inflammed with MPC & Contact bleeding. 
Gonorrhoea is associated with highest concentration of HIV-1 in semen. 
Gonococcal urethritis increases the infectiousness of men with HIV-1 infection. 
Prevalence rate of the disease is 12.2% in Delhi. 
Gonococcus from culture are identified by gram stain, oxidase test, 
fluorescent antibody test. Culture is the most reliable method for diagnosis. 
Individuals with gonorrhoea are at increased risk (approximately 40%) for 
chlamydial infection although reverse is not true. Latent chlamydial infections are 
reactivated in presence of gonorrhoea. 
BACTERIAL VAGINOSIS  
It is an alternation of normal bacterial vaginal flora, that result in the loss of 
H2O2 producing lactobacilli and over growth of predominantly anaerobic bacteria. 
It is not known what triggers the disturbance of normal vaginal flora. It has 
been postulated that repeated alkalinisation of the vagina which acquires with 
frequent sexual intercourse (or) uses of douches plays a role. After normal H2 O2 
 
producing lactobacilli disappear, it is difficult to reestablish normal vaginal flora 
and recurrence of BV is common. Numerous studies have shown an association of 
BV with adverse sequale. Women with BV are of increased risk for PID and  
PROM and Post Cesarean endrometritis. 
Diagnosis of bacterial vaginosis is based on the following findings. 
1. A fishy odour which is particularly noticeable following coitus and 
vaginal discharge are present. 
2. Vaginal secretions are grey and thinly coat the vaginal walls 
Patient’s vaginal PH  is 7.45. 
3. In advanced cases of BV more than 20% of the epithelial cells are 
clue cells. 
Prevalences of between 4.9% to 36% have been reported from European 
and American studies. Risk factors are smoking douching, multiple sex partners 
and intrauterine contraceptive users. 
Mycoplasma hominis has been found to cause slowing of mucociliary 
wave. They may interfere with transmission of spermatozoa in fertilization of ova 
directly. Antibodies to mycolplasma hominis occurred three times more often in 
women with tubal infertility. 
 
In another study by Wilson et al., one third of women with tubal factor 
infertility had bacterial vaginosis. Endometrial infection preceded ascending 
infection of the fallopian tubes. Korn et al., found plasma cell endometritis to be 
more frequently present in women with bacterial vaginosis. 
Mycoplasma genitalium infected women transmit HIV three times more 
often to their partners than other women. The increased frequency of HIV-1 
associated with abnormal flora among younger women suggests that loss of 
lactobacilli or presence of bacterial vaginosis may increase susceptibility to HIV 
infection. 
Early detection (clue cells on wet mount; and gram stain of vaginal 
secretion) and systemic antimicrobial therapy for bacterial vaginosis is necessary 
to prevent complications. 
TRICHOMONAL VAGINITIS  
Trichomonal vaginitis is caused by the sexually transmitted flagellated 
parasite – Trichomonas vaginalis. The transmission rate is high.  70% males 
contract the disease after single exposure to an infected female. 
The parasite is an anerobe and has the ability to generate hydrogen to 
combine with oxygen to create an anerobic environment. It exists only in 
 
hypophilic form Trichomonas vaginalis often accompany Bacterial vaginosis 
which can be diagnosed upto 60% Trichomonas vaginalis. 
Local immune factors and inoculum size influence the appearance of 
symptoms . 
Symptoms and signs may be much milder in patients with a smaller 
inoculation of Trichomonas vaginalis and is often asymptomatic. 
1. Trichomonas vaginalis is associated with profuse, purulent, 
malodourous discharge that may be accompanied by vulvar prutits.  
2. Vaginal secretion may exude from the vagina 
3. In patients with high concentration of organism a pachy vaginal 
erythema and straw berry cervix may be observed 
4. PH of the vaginal secretion is higher than 5. 
5. Microscopy of the secretion reveals motile trichomonads and 
increased number of leucocytes.  
6. Clue cells may be present 
7. Whiff test may be positive. 
Women with these infections should be tested for other STIs importantly   
Gonorrhea chlamydia and HIV. 
 
Speculum examination shows a friable and erythematous cervix with 
punctuate hemorrhages and ulceration (strawberry cervix, colpitis macularis). 
Male sexual partners may be asymptomatic or show evidence of urethritis, 
balanitis or epididymitis. 
Rarely ascending infection resulting in endometritis and salpingitis can 
occur. Diagnosis is confirmed by the microscopic demonstration of motile 
trichomonads in vaginal secretions mixed with normal saline. Culture in Feinberg-
Whittington or modified Diamond culture medium is more sensitive and specific. 
VULVOLVAGINAL CANDIDIASIS 
Candidal vaginitis is caused by candida albicans, with the anus being the 
source of recurrent infection of the vulva and vagina. 
If is present more frequently in diabetics, pregnant women, patients on 
broad spectrum antibiotics, contraceptive pills and corticosteroids, Changes in the 
host vaginal environment are necessary before the organism induces pathologic 
effect. 
Symptoms of candidal vaginitis include pruritus, dysuria, frequency of 
micturition, dyspareunia, post coital irritation and a thick curdy white vaginal 
discharge. 
 
Examination reveals cheesy, thrush like plaques and diffuse erythema of 
the vulva and vagina with excoriations, scaling and remote satellite pustules on the 
labia, perineum or inner thigh. 
Diagnosis of candidal vaginitis depends on the demonstration of the yeast 
by microscopic examination of the vaginal secretion in 10% KOH or by gram 
staining, culture on sabourads dextrose agar is helpful when microscopic 
examination proves negative. 
SYPHILIS 
Causative organism is Treponema pallidum which is a motile spirochete 
that is generally acquired by close sexual contact and transplacentally from the 
mother to fetus. 
Both congenital and acquired syphilis have early and late stages each of 
which has classical clinical features. 
Incubation period is 10-90 days. 
Early Syphilis (WHO<2yr) 
Primary Syphilis (chancre) – usually presents as a genital ulcer that is 
sharply demarcated, round or oval with slightly elevated edges, may be irregular 
 
and painless. Floor is red, smooth, shining, cursty, oozing serous exudates when 
squeezed, with an indurated base. 
Inguinal lymphnodes unilateral or bilateral, firm movable and nontender 
with no suppuration. 
Secondary Syphilis – Occurs 4-8 weeks after chancre. Fever, malaise, 
lymphadenopathy, rash (trunk, palm, soles), alopecia, condylomata lata, buccal 
snail track ulcer etc. 
Early latent syphilis – No symptoms only reactive serology. 
LATE SYPHILIS (WHO>2yrs) 
Late latent syphilis with no symptoms only reactive serology or gummas – 
“granulomas” occurring in skin, mucosa, bone, joints and rarely viscera. 
Cardiovascular syphilis can manifest with aortic aneurysm with or without aortic 
reguragitation. Neurosyphilis with tabes dorsalis may also manifest. 
Diagnostic tests used for syphilis are 
1. Darkfield examination (from primary and secondary lesion) 
2. Nonspecific treponemal tests-VDRL. It is a useful screening test becoming 
positive within 3-4wks of primary infection and negative by 6 months after 
 
treatment. It is a quantifiable test that can be used to monitor treatment 
efficacy. VDRL may be negative in untreated patients (50% with late stage 
syphilis). False positive results may occur in infectious mononucleosis 
hepatitis, mycoplasma infection and some protozonal infection. 
3. Specific treponemal tests 
TPHA – Treponema palladium Haemagglutination assay 
FTA ABS  - Fluorescent treponema antibodies absorbed test. 
PID 
PID is caused by micro organism, colonizing the endocervix ascending the 
endometrium and fallopian tubes. 
Acute PID is the most common and important complication of Sexually 
transmitted infections S. PID is the most common serious infection in women aged 
16-25yrs and the resultant morbidly exceeds that produced by all other infections. 
ETIOLOGY 
Polymicrobial infection is caused by organisms ascending from the vagina and 
cervix. 
 85% - Naturally occurring infection in sexually active women of 
reproductive age. 
 15% - After procedures that break the cervical mucous barrier 
 ORGANISMS 
N. gonorrhea 
- Ch. Trachomatis  
- Endogenous aerobic and anaerobic 
- Genital Myco plasma 
RISK FACTORS 
1. Age at first intercourse 
2. Frequency of intercourse 
3. Number of sexual partners 
4. Marital status 
5. Surgical procedures 
a. Endometrial biopsy 
b. IUCD 
c. Hysteroscopy 
d. HSG 
CLINICAL FEATURES 
1. Lower abdominal pain 
2. Cervical tenderness 
3. Adnexal tenderness 
4. Fever 
5. Cervical discharge 
 MINIMUM CRITERIA 
1. Uterine / adnexal  tenderness. 
2. Cervical Motion tenderness 
ROUTINE CRITERIA 
1. Oral temperature >38.3oC 
2. Abnormal cervical vaginal muco purulent discharge. 
3. ↑ ESR 
4. Elevated CRP 
5. Laboratory documentation of cervical infection of N.Gonorhhea or 
Chlamydia trachomatis. 
6. Presence of WBC on Saline microscopy. 
SPECIFIC CRITERIA  
1. HPE evidence of endometritis on Endometrial biopsy. 
2. TVS / MRI – fluid filled tubes with or without free pelvic fluid. 
- Laparoscopic examination consistent with PID 
Laparoscopy is the gold standard for diagnosis of PID and the correlation 
with clinical criteria ranges from 65% to 87%. 
 
Women who have had previous episodes of PID may develop a tuboavarian 
abscess suggested by pelvic pain and tenderness with a palpable pelvic mass. All 
male sexual partners of patients with PID should be examined for STD and treated 
accordingly. 
 
 
 
 
 
 
 
 
 
 
 
 
 4.  MATERIALS AND METHODS 
 
 
 
NATURE OF THE STUDY 
Infertile women attending infertility clinic are largely representative of the 
general population. 
It is a cross sectional study to find out the prevalence of STD among 
infertile women attending the infertility clinic at Govt. Raja Sir Ramaswamy 
Mudaliar Lying-in-Hospital, Stanley Medical College, Chennai -1 during the study 
period of June 2006 to July 2007. 
Prevalence data are important for directing and monitoring the impact of 
public health programes. 
MATERIALS 
Total number of 100 infertile women who attended the Raja Sir 
Ramaswamy Mudaliar Lying-in-Hospital Chennai -1 were included in the study. 
METHODS 
A well structured, pre tested proforma was prepared and used for the study. 
It consisted of various information including their age, socio-economic status, 
marital status, sexual history, previous obstetric history, apart from a  detailed 
 
clinical history. Infertile women were screened for STD and a provisional 
diagnosis was made. Investigations were done accordingly to confirm the 
diagnosis. 
INVESTIGATIONS 
a. Saline mount for Trichomonas Vaginalis – smear of vaginal secretion 
was made on a clean glass slide. One drop of normal saline was added, 
cover slip placed and motile trichomonas organisms were looked for 
under the microscope. 
b. KOH mount for candida 
 Smear of vaginal secretion  made on a clean glass side. One drop of 
KOH added, cover slip placed and look for pseudohyphae under the 
microscope. 
c. Gram stain for 
i. Candida – looked for gram+ve pseudohyphae 
ii. Clue cells - > 20% of vaginal squamous epithelial cells are 
granular in appearance with borders studied with cocco 
bacilli and gram negative rods. 
iii. Gonococcus – gram negative intracellular cocci in pairs. 
 
d. Endocervical culture for gonococcus – endocervical swab was 
transported by Amie’s medium to the laboratory and then inoculated 
into Thayer-Martin agar. Incubated in an atmosphere of increased 
carbon dioxide concentration (5-10% of CO2) colonies of gram 
negative cocci in pairs are seen. 
e. VDRL test for syphilis – It is a slide flocculation test. 0.05ml of 
inactivated serum was taken in special slides with depressions. One 
drop of freshly prepared antigen was added with a syringe delivering 
60 drops to it. The slide was rotated 180o rotations per minute in a 
VDRL rotator for four minutes. Then examined under a microscope. 
Formation of clumps indicates that it is reactive. Serial dilutions were 
tested to obtain reactive titre. 
 Special investigations done for the study were 
A. Vaginal discharge for culture of candida species  in sabourands agar 
medium. Sabourands medium is the commonest fungal culture media 
used. It consists of ingredients like glucose, cycloheximide and agar. 
Sterile vaginal swabs were used for taking specimens. Cultures 
incubated at room temperature (22 o C) for 2 weeks. 
 
Identification was based on colony appearance (creamy, white, mucoid) and 
the morphology of the fungus examined by microscopy. The method of identifying 
candida albicans was based on its ability to form germ tubes within two hours 
when incubated in human serum at 37 oC 
B. Chlamydia antigen detection test – Endocervical smear was taken in a 
sterile swab after wiping the external os with a cotton swab. The sterile swab was 
kept inside the endocervical canal for 10 seconds and scraping were spread over 
the chalmyset antigen detecting Teflon coated slide. The chlamyset slide was held 
in one hand and the sampling swab was rolled over the 8mm circular area on the 
slide. This was best done after sampling, rolling one side of swab on one half of 
the sample well and the other side of the swab on the other half of the sample well. 
The slide was allowed to dry completely in the air (until the surface has lost 
its glossy appearance). Then the specimen was fixed by dipping the slide in 
methanol in a staining jar for 5 minutes and allowed to evaporate to dryness. 
Test procedure – 30 microlitre of chalamyset antigen FA test reagent was 
addred to fixed specimens and the slides were placed in a moist container 
incubated horizontally at room temperature for 15 minutes. Then the slides were 
rinsed by dipping it into distilled water several times and made to dry 20 
microlitres of chlamyset mounting fluid was added to the specimens and a cover 
 
slip was placed over it. Then the slides were examined under a fluorescent 
microscope using 400% magnification (for screening) and 1000% magnification 
(for verifying the findings). 
C. Sero ELISA Chlamydia true IgM test – This test was intended for the 
determination of specific IgM antibody to Chlamydia in a single human serum 
sample by an Enzyme – linked immunosorbent assay (ELISA). 
Chlamydia-specific IgM antibody appears to be reliable immunological 
marker of acute or recent infection. This test requires only a single serum 
specimen and result is reported in terms of presence or absence of immune IgM. 
High titres of immune IgG, which compete with immune IgM for the same 
antigenic sites, produce false negative IgM results. Rheumatoid factor (RF) causes 
false positive IgM results. Therefore IgG/RF stripping of serum is essential before 
the IgM assay. 
The test employs the L2 serovar broadly reacting antigen of 
C.trachomatous. Advantages of this test are it does not require direct pathogen 
sampling, and is suitable for automated processing of the test procedure and 
reading of results. 
 
 5.  OBSERVATIONS 
 
 
In this study 100 infertile women were examined and the following results 
were obtained : 
TABLE – 1 
AGE DISTRIBUTION OF INFERTILE 
WOMEN IN THE STUDY GROUP (n-100) 
 
 
 
Age in years Total no. Percentage % 
15-19 Years 4 4% 
20-24 years 43 43% 
25-29 years 51 51% 
30-34 years 1 1% 
35 years and above 1 1% 
 
Majority of infertile, women were in the age group of 20-24 years (52%). 
The youngest and oldest infertile women encountered in the study were aged 17 
and 37 years respectively. 
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TABLE – 2 
SOCIO-ECONOMIC STATUS OF INFERTILE (n-100) 
WOMEN IN STUDY GROUP 
 
 
 
Monthly Income 
(in Rupees) 
Total no. Percentage % 
Upto 500 48 48% 
500-1000 40 40% 
1000-1500 6 6% 
1500-2000 6 6% 
Above 2000 Nil  
 
Majority of the infertile, women belonged to lower socio economic strata 
48% ie. Income less than Rs.500. 
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TABLE – 3 
MARITAL STATUS OF THE INFERTILE WOMEN 
IN THE STUDY GROUP (n-100) 
 
 
 
No. of years of  
Marriage 
Total No. Percentage % 
1-5 years 75 75% 
6-10 years 20 20% 
11-15 years 5 5% 
 
Majority of  infertile, women were married for 1-5 years (75%). The lowest 
and the highest duration of married life among infertile women encountered in the 
study group were 1 ½ years and 13 years respectively. 
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TABLE – 4 
PRESENTING COMPLAINTS OF INFERTILE WOMEN (n-100) 
IN THE STUDY 
 
 
 
Complaints Total no. 
Genital Discharge 8 
Irregular Periods 41 
Itching of genitalia 4 
Lower abdominal Pain 7 
Burning micturition 1 
Genital ulcer Nil 
 
All the 100 patients had visited the infertility clinic since they were anxious 
to conceive which was the main complaint. 
Irregular periods was the most common presenting complaint in 41% of 
patients apart from infertility. 8% of patients gave a history of genital discharge 
 
out of which 4 patients had associated itching. 7% of patients complained of lower 
abdominal pain. One patient had burning micturition 
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TABLE – 5 
FREQUENCY OF COITUS PER WEEK 
 
 
Coitus Total no. Percentage % 
More than 3 times 74 74% 
Less than 3 times 26 26% 
 
The frequency of coitus was more than three times a week in the majority 
of patients (74%) showing that the majority of patients were sexually active. 
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TABLE – 6 
PREMARITAL / EXTRAMARITAL CONTACTS 
AMONG MARRIED INFERTILE WOMEN (n-100) 
 
 
 
Contacts Total no. Percentage % 
Extra marital contact Nil - 
Pre marital contact Nil - 
Extra marital contact + 
pre marital contact 
- - 
 
 
When married infertile women were interviewed for the study none gave a 
history of extra marital or premarital contact showing that all the women in the 
study are monogamous. 
 
 
 
TABLE – 7 
PAST HISTORY OF SEXUALLY TRANSMITTED DISEASES (STD) IN 
THE STUDY GROUP 
 
 
  
Past history of STD Total no. Percentage % 
Present Nil - 
Absent 100 100% 
 
 
None of the 100 infertile women give a past history of documented STD or 
treatment for the same. 
 
 
 
 
 
TABLE – 8 
BAD OBSTETRIC HISTORY (BOH) 
  
Bad Ostetric  Total no. Percentage % 
Spontaneous abortion 11 11% 
Still born 1 1% 
Neonatal death Nil - 
 Spontaneous abortion and 
still birth 
1 1% 
 
Bad obstetric history was found in 13 patients out of 100 infertile women 
screened in the study. Majority had spontaneous abortion 11% followed by still 
birth (1%). One woman had a spontaneous abortion and still birth. 
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TABLE – 9 
CLINICAL SIGNS IN THE STUDY GROUP 
OF INFERTILE WOMEN (n-100) 
 
 
 
Clinical signs Total no. Percentage % 
Cervical erosion 36 36% 
Soddening of vulva 2 2% 
Excoriation of vulva Nil Nil 
Cervical motion 
tenderness 
3 3% 
Intertrigo groin Nil Nil 
Cervical hypertrophy 30 30% 
Fornix tenderness 5 5% 
Bilateral inguinal 
lymphadenopathy 
Nil Nil 
 
Cervical erosion was the most common clinical sign seen in 36% of  
infertile women. Cervical hypertrophy was the next most common sign seen in 
30% of infertile women, followed by tenderness in the fornix. 
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TABLE – 10 
 
NATURE OF GENITAL DISCHARGE AMONG 
THE STUDY GROUP  (n-100) 
 
 
Nature of Discharge Total no. Percentage % 
Mucopurulent 12 12% 
Mucoid 23 23% 
Curdy white 3 3% 
Frothy 1 1% 
Associated foul smelling 2 2% 
Associated itching 4 4% 
 
Majority of infertile women had mucoid discharge 23% followed by a 
mucopurulent discharge 12% curdy white 3% and frothy 1%. Out of the 39 
patients who had a genital discharge, the discharge was foul smelling in 2% and 
4% of patients had associated itching with discharge. Only 8% of study group 
complained of genital discharge as a symptom. But on examination 39% of the 
patients had genital discharge. 
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RESULTS OF INVESTIGATION IN THE STUDY GROUP OF 
INFERTILE WOMEN (n-100) 
 
 
Investigation Positive results  
Total No. 
Percentage % 
Culture for candida 7 7% 
Gram Stain for candida 5 5% 
KOH mount for candida 4 4% 
Wet film for trichomonas vaginalis 10 10% 
Gram stain for clue cells 2 2% 
Endocervical culture for gonococcus Nil Nil 
Gram stain for gonococcus Nil Nil 
Chlamydia antigen detection test 26 26% 
Chlamydia IgM antibody ELISA test 20 20% 
VDRL Nil Nil 
 
 
 
 
Out of the 100 infertile women endocervical smear was positive for 
Chlamydia antigen in 26% of patients. ELISA test for IgM antibody was positive 
in 20% of  patients making it the most common infection. 
Wet film for trichomonas was positive in 10% of patients making it the 
second most common infection closely followed by candida. 7% of patients 
showed culture of candida species on Sabouraurd’s dextrose agar medium. 
Candida albicans was the most common isolated species. Bacterial vaginosis was 
diagnosed in 2% of patients. 
Endocervical culture for gonococcus and VDRL test for syphilis was 
negative in all patients showing that these infections are declining. 
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TABLE – 12 
CONCOMITANT INFECTIONS IN STUDY 
GROUP OF INFERTILE WOMEN 
 
 
Infections Total no. Percentage % 
Trichomonas vaginalis+ chlamydia 4 4% 
Candidiasis+Chlamydia cervicitis 4 4% 
Chlamydia 1 1% 
PID + Trichomonas vaginalis 2 2% 
 
Concomitant infections with Chlamydia was found in 8% of patients, half 
was along with trichomonas and the other half with candida. 
Six patients fulfilled the criteria for diagnosis of PID in this study. Four of 
them had concomitant infection two with Trichomonas vaginalis, one with 
Chlamydia and one patient had both trichomonas & chlamdia along with PID. 
 
 
 6.  DISCUSSION 
 
 
In this study, majority of infertile women were in the age group of 20-24 
years followed by 25-29 years. A significant number of infertile women were 
below 19 years of age. Due to early initiation of sexual activity they are more 
prone for STD. 
Majority of infertile women belonged to the lower socio economic status. 
Low socio economic status often coexists with poor nutritional status and poor 
personal hygiene of women that in turn affects the course of the disease. 
Majority of the infertile women in this study were married for less than 5 
years. The patients in this study had visited the infertility clinic with chief 
complaint of being anxious to conceive. The most common presenting complaint 
other than infertility was various menstrual irregularities. Very few had complaints 
like discharge and itching relating to the genitourinary system. 
However on clinical examination and completion of investigations it was 
seen that 45% of infertile women were suffering from infections. This shows that 
nearly half the infertile women with infections were asymptomatic. Chlamydia 
was the most common infection presenting without symptoms. 14 patients out of 
26 patients with chalmydia had no symptoms i.e. 53.8% were asymptomatic. The 
 
significance of this is that infertile women may not be aware of the silent clinical 
states of Chlamydia. This may lead to delay in detection, so progression of the 
disease leading to complications is common. 
The case of Chlamydia associated with symptoms were coexistent with 
other infections like trichomonas, candida. Only two cases of Chlamydia, not 
associated with other infections presented with symptoms. One patient had 
complaint of burning micturition but was not associated with Chlamydia. Early 
diagnosis by routine screening for STD will greatly help in detection in the initial 
stages so that effective intervention can be done. 
All the women in this study denied history of premarital or extramarital 
contact showing that all had monogamous relationship. Majority were sexually 
active. This stresses the fact that innocent women were infected by their 
promiscuous husbands and were exposed to high risk of acquiring STD resulting 
in morbidity and mortality. 
Bad obstetric history was noted in a significant proportion of infertile 
women-13%. Among these one woman had trichomonas vaginals infection, 
another had candidiasis and the third had PID but the majority had no associated 
infection. 
 
In the study group cervical erosion, cervical hypertrophy and fornix 
tenderness were the important clinical signs  noted. Erosion of the cervix was seen 
in 36% of women. Erosion or cervical ectopy enhances the entry of a variety of 
pathogenic agents (eg HPV, HIV, HSV, Trichomonas, chlamydia etc). These 
women are prone for STD. 
In this study mucoid vaginal discharge was commonly seen in 23% of 
patients which usually does not signify any pathology. Next common was 
mucopurulent discharge in 12% of patients. Patients with trichomonas vaginalis 
had predominatly mucopurulent discharge and the typical frothy discharge of 
trichomonas was seen in only one patient. The usual description of discharge in 
vulvovaginal candidiasis is curdy white and adherent. In this study only 3% of the 
infertile women had the above said clinical sign. Majority of these patients had no 
symptoms and the discharge was noted on routine speculum examination, a few 
complained of itching in the genitalia. Two patients had bacterial vaginosis and 
their genital discharge was mucoid in nature. 
The prevalence of Chlamydia was the highest 26% in this study compared 
to other infections. This is comparable to the worldwide prevalence of 24.1%-
27%. The prevalence of trichomonas vaginalis in this study population was 10%. 
There is very little information on the world wide prevalence of trichomonas. The 
prevalence of genital candida is 7% in this study. The world wide prevalence is 
 
5%-15%. More than half the patients with candidiasis had other associated STDs. 
Prevalence of bacterial vaginosis in this study was only 2%. Prevalences between 
4.9% to 36% have been reported from European and American studies. Prevalence 
of PID was 6% in this study. The prevalence of PID is 17% -40% of all 
gynaecological admissions in South East Asia. None of the patients harboured 
gonococcal infection showing that the prevalence is declining. Gonorrhea rates in 
the United States declined 56% between 1984 & 1994. One study showed the 
prevalence rate of gonococcus in New Delhi is 12.2%. None of the patients had 
syphilis infection. The world wide prevalence of syphilis is 5 per 100,000 but in 
developing countries it is still between 2.7% - 26.6%. Oxford clinical trials – 2005 
Manhatten study showed that prevalence of Chlamydia infections among 
subfertile women found to be 1.7 to 20%. 
Concomitant infections were present in this study. Most infection coexisted 
with Chlamydia. 5 patients with trichomonas (i.e.50%) and 4 patients with candida 
(i.e.57.1%) had concomitant infection with Chlamydia. Patients with Chlamydia 
presenting with symptoms were more likely to have yeast 24% or trichomonas 
infection 20% coexisting. (Hilton et al., 1974 STD clinic in UK). The above 
patients would have been missed if treatment of vaginal organisms resolved the 
symptoms. Individuals with gonorrhoea are at increased risk (approximately 40%) 
for a chlamydial infection, although the reverse is not true. Latent chlamydial 
infections are reactivated in the presence of gonorrhoea.  
 
  
7.  CONCLUSION 
 
 
This study revealed that majority of infertile women were found to be 
asymptomatic as regards genitourinary symptoms even though they harboured 
infections. The study also revealed the high prevalence of Chlamydia. The 
prevalence of gonococcus and sphyllis is declining. 
The important risk factor for sexually transmitted diseases noticed in this 
study was promiscuity among husbands of infertile women. Health education 
regarding transmission of sexually transmitted diseases (STDs), safer sex and 
counseling should be made available to them. Prompt treatment of infected 
persons and their partner by early detection will prevent further disease 
transmission. It will also minimise severity of long term sequelae. Hence 
systematic screening of sexually transmitted infection in infertile women 
combined with adequate treatment and follow up will reduce the risk of adverse 
consequences and improve the fertility. 
STD’s often coexist and a search for them should be instituted in every 
patient. Routine screening in all infertile women for sexually transmitted infection 
should be included in infertility clinics. Effective treatment services should be 
made widely available for those who are found to be infected. 
 
 
To conclude, there is an urgent need to mount effective, rational and 
plausible intervention programmes to combat STD pandemic, making optimum 
use of the existing health social welfare services. 
 
 
 
 
 
 
 
 
 
 
 
 MASTER CHART 
 
 
Name 
 
 
Age 
 
S.E. 
Status 
Duration 
of M.L 
Years 
Presenting 
Compliants 
 
Type of 
Discharge 
 
 
BOH 
 
Clinical Signs Result of
    IMC V.D L.A.P.   Cervix 
Unhealth 
Fornix 
tenderness 
irami 33 IV 2 + - - - - + - Chlam
gavani 25 IV 3 - - - - - - - -
itra 30 IV 2 ½ - - - - - - - -
ttammal 30 IV 2 + - - - - - - Chlam
staldevi 30 IV 1 ½ - - - - - - - -
hima 30 III 4 + - - - - - - -
geswari 27 IV 10 + - - - - - - -
mathi 29 V 2 - + - Frothy - + - TV
eela 28 IV 9 + + - Mucopurulent - - - Chlam
lochana 21 IV 5 - - - - - + - -
eralakshmi 30 IV 7 - - - - - - - -
kshmi 30 V 8 - - - - - - - -
dhika 27 III 6 + - - - - - - -
ythili 23 IV 6 + - - - - - - -
yamani 22 IV 3 - + - - - - - Candia+C
thi 24 IV 3 + - - - - - - -
itra 24 V 5 + - - - - + - -
ammal 23 V 5 - - - - - + - -
dira 23 V 2 - + - Mucopurulent - + - Chlam
galakshmi 20 V 10 - - - - - + - -
sikala 33 IV 4 - + - Curdy - + - Cand
athi 28 23 IV 2 - - - - + - -
myaiave 23 24 IV 3 - - - - + - Chlam
allithy 38 IV 4 + - - - - - - -
hya 20 IV 3 + - - Mucoid - + - -
nodhini 26 IV 3 - + + Mucopurulent - + + TV+Chl
laivani 38 V 8 - + + Mucopurulent - + - Chlamyd
ahalakshmi 25 IV 4 - - - Mucopurulent - + - TV
raswathi 29 V 10 - + - Mucoid - - - B.V
rya 24 29 III 4 - - - - - - -
sodha 27 IV 13 + - - - - - - -
vi 20 V 2 + - - - - - - -
 
vi 27 V 9 + - - - - - - -
angai 23 IV 10 - + + Mucopurulent - + - TV+P
rya 24 V 2 + - - Mucoid - - - Chlam
armila 24 V 2 ½  + - - - + - - Cand
analaxmi 22 IV 3 + - - - - + - -
vi 22 V 5 - + - Curdy - - - Candida C
ni 26 IV 8 + - - - - + - -
amin 25 V 5 - - - - - - - -
anjula 24 V 2 + + + Mucoid - + + TV + 
rmala 21 III 1 ½  - + - - + + - -
abana 22 IV 4 - + - - - + - -
lpana  21 V 1 ½ + - - - + + - -
nsi 25 V 1 ½ - + - Mucopurulent - + - TV+Chl
shpalatha 24 II 2 + - - - - - - -
itha 28 IV 6 + + - Mucopurulent + + - TV
mpoornam 25 IV 9 + + + Curdy - + - Cand
tteswari 24 IV 2 ½ - - - - - - - Chlam
pathy 22 IV 5 - - - - - - - -
enalagi 32 V 2 ½ + - - - - - - -
la 30 IV 11 - - - - - - - -
samma 25 V 8 - - - - + - - -
ppama 23 V 3 - - - - - + - -
erin 28 IV 10 - + - Mucoid + + + PID
ngeetha 25 V 4 - - - - - - - -
vagami 20 V 5 - - - - + - - -
usuya 23 IV 3 + - - Mucoid + + - -
anthi 30 IV 8 + + + Mucoid - + + PID
sheela 23 IV 3 + - - - - - - -
ma 24 IV 4 - - - - + + - -
ma 21 V 1 ½ - - - Mucoid - + - Chlam
naki 26 V 5 + - - Mucoid - + - Chalm
smin 19 V 2 + - - - - - - Chalm
amelu 25 V 5 - - - Mucoid - - - -
mil Selvi 23 V 5 - - - Mucoid - - - -
kshmi 25 IV 3 - + - Mucoid - - - BV
vindamma 26 V 8 + - - Mucoid - + - Chlam
enmozhi 27 V 6 + - - - - + - -
  
ABBREVIATIONS 
IMC - Irregular Menstrual Cycles  S.E. - Socio Economic Status
 PID - Pelvi Inflammatory Disease 
VD - Vaginal Discharge   BOH - Bad Obstetric History 
L.A.P - Lower Abdominal Pain   TV - Trichomonas Vaginalis 
 
vi 23 V 4 - + - Mucopurulent - + - TV+Chl
mudha 23 IV 2 - - - Mucoid - - - -
tha 26 IV 3 - - - Mucoid - + - Chlam
anjula 25 V 3 ½  - + + Mucopurulent - + + Chlam
dira 21 IV 5 - - - Mucoid - + - -
vagami 30 IV 12 - - - Mucoid + + - -
ala 19 V 1 ½ - + - Mucopurulent - + - TV+Cha
mala 22 IV 3 ½ - - - - - - - -
amundeswari 22 IV 2 - - - Mucoid + - - -
itra 20 V 4 - - - - - + - -
rpagam 22 V 3 - - - - - - - -
lpana  25 IV 3 - + - - + + - -
ya 25 IV 5 + - - - - - - -
tha 24 V 3 ½ + + - Curdy - + - Candida+ C
ni 25 V 5 - - - - - - - -
dhika 19 V 1 ½ - - - - - - - -
vagami 27 V 5 - - - Mucoid - - - -
wdamani 20 V 4 - - - - + - - -
mulu 20 V 3 - - - Mucoid - - - Chlam
ya 21 V 5 + - - - - + - -
ya 23 V 4 + - - - - + - -
enila 24 V 5 - - - - - - - -
navathi 28 V 5 - - - - - - - -
anthi 34 V 13 - + - Mucopurulent - + - Candida+C
amala 18 V 2 - - - Mucoid - - - Chlam
adona 30 IV 2 - + - Mucoid - + - -
dma 22 IV 8 + - - - - - - -
ya 21 V 2 + - - - - - - -
vi 22 V 1 ½ - - - - - - - -
nalakshmi 22 IV 2 + - - Mucoid - - - Chalm
mala 23 IV 3 - + - Mucoid - + - Chalm
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